000 | 01841 a2200565 4500 | ||
---|---|---|---|
005 | 20250514221057.0 | ||
264 | 0 | _c20050411 | |
008 | 200504s 0 0 eng d | ||
022 | _a0022-2623 | ||
024 | 7 |
_a10.1021/jm049339c _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLowe, Richard F | |
245 | 0 | 0 |
_aRational design, synthesis, and structure-activity relationships of aryltriazoles as novel corticotropin-releasing factor-1 receptor antagonists. _h[electronic resource] |
260 |
_bJournal of medicinal chemistry _cMar 2005 |
||
300 |
_a1540-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBlood-Brain Barrier _xmetabolism |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aCyclic AMP _xbiosynthesis |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 |
_aFibroblasts _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aModels, Molecular |
650 | 0 | 4 | _aMolecular Conformation |
650 | 0 | 4 | _aRadioligand Assay |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptors, Corticotropin-Releasing Hormone _xantagonists & inhibitors |
650 | 0 | 4 | _aStereoisomerism |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 |
_aTriazoles _xchemical synthesis |
650 | 0 | 4 | _aCRF Receptor, Type 1 |
700 | 1 | _aNelson, Jodene | |
700 | 1 | _aDang, Trunghau N | |
700 | 1 | _aCrowe, Paul D | |
700 | 1 | _aPahuja, Anil | |
700 | 1 | _aMcCarthy, James R | |
700 | 1 | _aGrigoriadis, Dimitri E | |
700 | 1 | _aConlon, Paul | |
700 | 1 | _aSaunders, John | |
700 | 1 | _aChen, Chen | |
700 | 1 | _aSzabo, Thomas | |
700 | 1 | _aChen, Ta Kung | |
700 | 1 | _aBozigian, Haig | |
773 | 0 |
_tJournal of medicinal chemistry _gvol. 48 _gno. 5 _gp. 1540-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm049339c _zAvailable from publisher's website |
999 |
_c15417144 _d15417144 |